More on ODTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $24.52 |
|
|||
| Open | $24.21 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $25.23 | ||||
| Day Low | $24.06 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 172,831 | ||||
- H.C. Wainwright Starts Odyssey Therapeutics (ODTX) at Buy
- Odyssey Therapeutics to Participate in Upcoming Investor Conferences
- Odyssey Therapeutics (ODTX) PT Raised to $29 at JPMorgan
- Form 10-Q Odyssey Therapeutics, For: Jun 30
- Evotec and Odyssey partner on autoimmune drug discovery
- Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
- Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Wedbush Starts Odyssey Therapeutics (ODTX) at Outperform
- Cantor Fitzgerald Starts Odyssey Therapeutics (ODTX) at Overweight
Entities mentioned with ODTX
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- S1 | View Related Stories »
- Show More...
